Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cells

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Wang, Xuewei ^a   Nath, Aritro ^b   Yang, Xuerui ^a,c   Portis, Amanda ^a   Walton, S Patrick ^a   Chan, Christina ^a,b,c  

^a Michigan State University   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Michigan State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPLAKIN; INSULIN; PALMITIC ACID; PALMITIC ACID DERIVATIVE;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CELL DEATH; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; METABOLISM; PHENOTYPE;

CELL DEATH; DESMOPLAKINS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HEP G2 CELLS; HUMANS; INSULIN; PALMITATES; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 81755171963     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028138     Document Type: Article

References (84)

1. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, et al. (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115: 1343-1351.
2. Angulo P, (2007) Obesity and nonalcoholic fatty liver disease. Nutr Rev 65: S57-63.
3. Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, et al. (2003) Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 37: 909-916.
4. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, et al. (2007) Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol 47: 711-717.
5. Musso G, Gambino R, Cassader M, (2009) Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 48: 1-26.
6. Li Z, Srivastava S, Mittal S, Yang X, Sheng L, et al. (2007) A Three Stage Integrative Pathway Search (TIPS) framework to identify toxicity relevant genes and pathways. BMC Bioinformatics 8: 202.
7. Li Z, Srivastava S, Yang X, Mittal S, Norton P, et al. (2007) A hierarchical approach employing metabolic and gene expression profiles to identify the pathways that confer cytotoxicity in HepG2 cells. BMC Syst Biol 1: 21.
8. Srivastava S, Li Z, Yang X, Yedwabnick M, Shaw S, et al. (2007) Identification of genes that regulate multiple cellular processes/responses in the context of lipotoxicity to hepatoma cells. BMC Genomics 8: 364.
9. Yang X, Zhou Y, Jin R, Chan C, (2009) Reconstruct modular phenotype-specific gene networks by knowledge-driven matrix factorization. Bioinformatics 25: 2236-2243.
10. Li Z, Srivastava S, Findlan R, Chan C, (2008) Using dynamic gene module map analysis to identify targets that modulate free fatty acid induced cytotoxicity. Biotechnol Prog 24: 29-37.
11. Remenyi A, Scholer HR, Wilmanns M, (2004) Combinatorial control of gene expression. Nat Struct Mol Biol 11: 812-815.
12. Srivastava S, Chan C, (2008) Application of metabolic flux analysis to identify the mechanisms of free fatty acid toxicity to human hepatoma cell line. Biotechnol Bioeng 99: 399-410.
13. Anastassiou D, (2007) Computational analysis of the synergy among multiple interacting genes. Mol Syst Biol 3: 83.
14. Bugianesi E, McCullough AJ, Marchesini G, (2005) Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 42: 987-1000.
15. Ruddock MW, Stein A, Landaker E, Park J, Cooksey RC, et al. (2008) Saturated fatty acids inhibit hepatic insulin action by modulating insulin receptor expression and post-receptor signalling. J Biochem 144: 599-607.
16. Getsios S, Huen AC, Green KJ, (2004) Working out the strength and flexibility of desmosomes. Nat Rev Mol Cell Biol 5: 271-281.
17. Rampazzo A, Nava A, Malacrida S, Beffagna G, Bauce B, et al. (2002) Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 71: 1200-1206.
18. Vinken M, Papeleu P, Snykers S, De Rop E, Henkens T, et al. (2006) Involvement of cell junctions in hepatocyte culture functionality. Crit Rev Toxicol 36: 299-318.
19. Cao Y, Chang H, Li L, Cheng RC, Fan XN, (2007) Alteration of adhesion molecule expression and cellular polarity in hepatocellular carcinoma. Histopathology 51: 528-538.
20. Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, et al. (2011) NCBI GEO: archive for functional genomics data sets-10 years on. Nucleic Acids Res 39: D1005-1010.
21. Yang X, Wang X, Wu M, Dalkic E, Chan C, (2009) Construction of the gene network by synergy analysis of the genes related to palmitate-induced cytotoxicity. In: Jayaraman A, Hahn J, editors. Methods in Bioengineering in Systems Analysis of Biological Networks: Artech House Publishers pp. 75-93.
22. Watkinson J, Wang X, Zheng T, Anastassiou D, (2008) Identification of gene interactions associated with disease from gene expression data using synergy networks. BMC Syst Biol 2: 10.
23. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate- a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological 57: 289-300.
24. Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Montano A, (2007) GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol 8: R3.
25. Zhang J, Li J, Deng H, (2008) Class-specific correlations of gene expressions: identification and their effects on clustering analyses. Am J Hum Genet 83: 269-277.
26. Dettling M, Gabrielson E, Parmigiani G, (2005) Searching for differentially expressed gene combinations. Genome Biol 6: R88.
27. Guo W, Wong S, Xie W, Lei T, Luo Z, (2007) Palmitate modulates intracellular signaling, induces endoplasmic reticulum stress, and causes apoptosis in mouse 3T3-L1 and rat primary preadipocytes. Am J Physiol Endocrinol Metab 293: E576-586.
28. Zhou Q, Du J, Hu Z, Walsh K, Wang XH, (2007) Evidence for adipose-muscle cross talk: opposing regulation of muscle proteolysis by adiponectin and Fatty acids. Endocrinology 148: 5696-5705.
29. Draghici S, Khatri P, Tarca AL, Amin K, Done A, et al. (2007) A systems biology approach for pathway level analysis. Genome Res 17: 1537-1545.
30. Swagell CD, Henly DC, Morris CP, (2005) Expression analysis of a human hepatic cell line in response to palmitate. Biochem Biophys Res Commun 328: 432-441.
31. Tsang MY, Cowie SE, Rabkin SW, (2004) Palmitate increases nitric oxide synthase activity that is involved in palmitate-induced cell death in cardiomyocytes. Nitric Oxide 10: 11-19.
32. Yang X, Nath A, Opperman MJ, Chan C, (2010) The double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cells. Mol Biol Cell 21: 3449-3458.
33. de la Fuente A, (2010) From 'differential expression' to 'differential networking'- identification of dysfunctional regulatory networks in diseases. Trends Genet 26: 326-333.
34. Smith JJ, Ramsey SA, Marelli M, Marzolf B, Hwang D, et al. (2007) Transcriptional responses to fatty acid are coordinated by combinatorial control. Mol Syst Biol 3: 115.
35. Sumi K, Tanaka T, Uchida A, Magoori K, Urashima Y, et al. (2007) Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8. Mol Cell Biol 27: 4248-4260.
36. Tan NS, Shaw NS, Vinckenbosch N, Liu P, Yasmin R, et al. (2002) Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 22: 5114-5127.
37. Slawik M, Vidal-Puig AJ, (2006) Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res Rev 5: 144-164.
38. Amemiya-Kudo M, Oka J, Ide T, Matsuzaka T, Sone H, et al. (2005) Sterol regulatory element-binding proteins activate insulin gene promoter directly and indirectly through synergy with BETA2/E47. J Biol Chem 280: 34577-34589.
39. Higuchi N, Kato M, Shundo Y, Tajiri H, Tanaka M, et al. (2008) Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res 38: 1122-1129.
40. Reed BD, Charos AE, Szekely AM, Weissman SM, Snyder M, (2008) Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes. PLoS Genet 4: e1000133.
41. Wang X, Dalkic E, Wu M, Chan C, (2008) Gene module level analysis: identification to networks and dynamics. Curr Opin Biotechnol 19: 482-491.
42. Mattar SG, Velcu LM, Rabinovitz M, Demetris AJ, Krasinskas AM, et al. (2005) Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 242: 610-617; discussion 618-620.
43. Han SF, Deng RL, Xu HR, Cao YF, Wang XY, et al. (2007) [Photosynthesis and active-oxygen-scavenging enzyme activities in rice varieties with different phosphorus efficiency under phosphorus stress]. Ying Yong Sheng Tai Xue Bao 18: 2462-2467.
44. Lorch JH, Klessner J, Park JK, Getsios S, Wu YL, et al. (2004) Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. J Biol Chem 279: 37191-37200.
45. Hegmans JP, Bard MP, Hemmes A, Luider TM, Kleijmeer MJ, et al. (2004) Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol 164: 1807-1815.
46. Chidgey M, Dawson C, (2007) Desmosomes: a role in cancer? Br J Cancer 96: 1783-1787.
47. Whittock NV, Wan H, Morley SM, Garzon MC, Kristal L, et al. (2002) Compound heterozygosity for non-sense and mis-sense mutations in desmoplakin underlies skin fragility/woolly hair syndrome. J Invest Dermatol 118: 232-238.
48. Yang Z, Bowles NE, Scherer SE, Taylor MD, Kearney DL, et al. (2006) Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res 99: 646-655.
49. Jonkman MF, Pasmooij AM, Pasmans SG, van den Berg MP, Ter Horst HJ, et al. (2005) Loss of desmoplakin tail causes lethal acantholytic epidermolysis bullosa. Am J Hum Genet 77: 653-660.
50. Uzumcu A, Norgett EE, Dindar A, Uyguner O, Nisli K, et al. (2006) Loss of desmoplakin isoform I causes early onset cardiomyopathy and heart failure in a Naxos-like syndrome. J Med Genet 43: e5.
51. Targher G, Marra F, Marchesini G, (2008) Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 51: 1947-1953.
52. Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, et al. (2010) Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J Hepatol 53: 713-718.
53. Edens MA, Kuipers F, Stolk RP, (2009) Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers. Obes Rev 10: 412-419.
54. Ekinci FJ, Shea TB, (1999) Free PKC catalytic subunits (PKM) phosphorylate tau via a pathway distinct from that utilized by intact PKC. Brain Res 850: 207-216.
55. Leitges M, Plomann M, Standaert ML, Bandyopadhyay G, Sajan MP, et al. (2002) Knockout of PKC alpha enhances insulin signaling through PI3K. Mol Endocrinol 16: 847-858.
56. Hobbs RP, Amargo EV, Somasundaram A, Simpson CL, Prakriya M, et al. (2010) The calcium ATPase SERCA2 regulates desmoplakin dynamics and intercellular adhesive strength through modulation of PKC{alpha} signaling. FASEB J.
57. Bass-Zubek AE, Hobbs RP, Amargo EV, Garcia NJ, Hsieh SN, et al. (2008) Plakophilin 2: a critical scaffold for PKC alpha that regulates intercellular junction assembly. J Cell Biol 181: 605-613.
58. Garcia-Gras E, Lombardi R, Giocondo MJ, Willerson JT, Schneider MD, et al. (2006) Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest 116: 2012-2021.
59. Polakis P, (2000) Wnt signaling and cancer. Genes Dev 14: 1837-1851.
60. Abiola M, Favier M, Christodoulou-Vafeiadou E, Pichard AL, Martelly I, et al. (2009) Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells. PLoS One 4: e8509.
61. Yoon JC, Ng A, Kim BH, Bianco A, Xavier RJ, et al. (2010) Wnt signaling regulates mitochondrial physiology and insulin sensitivity. Genes Dev 24: 1507-1518.
62. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395.
63. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, et al. (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44: 865-873.
64. de Alwis NM, Day CP, (2008) Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 48 (Suppl 1): S104-112.
65. Smith J, Su X, El-Maghrabi R, Stahl PD, Abumrad NA, (2008) Opposite regulation of CD36 ubiquitination by fatty acids and insulin: effects on fatty acid uptake. J Biol Chem 283: 13578-13585.
66. Gao D, Nong S, Huang X, Lu Y, Zhao H, et al. (2010) The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J Biol Chem 285: 29965-29973.
67. Franch-Marro X, Wendler F, Griffith J, Maurice MM, Vincent JP, (2008) In vivo role of lipid adducts on Wingless. J Cell Sci 121: 1587-1592.
68. Borradaile NM, Buhman KK, Listenberger LL, Magee CJ, Morimoto ET, et al. (2006) A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death. Mol Biol Cell 17: 770-778.
69. Leonardi R, Zhang YM, Rock CO, Jackowski S, (2005) Coenzyme A: back in action. Prog Lipid Res 44: 125-153.
70. Huang L, Yan M, Kirschke CP, (2010) Over-expression of ZnT7 increases insulin synthesis and secretion in pancreatic beta-cells by promoting insulin gene transcription. Exp Cell Res.
71. Nicolson TJ, Bellomo EA, Wijesekara N, Loder MK, Baldwin JM, et al. (2009) Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 58: 2070-2083.
72. Smidt K, Jessen N, Petersen AB, Larsen A, Magnusson N, et al. (2009) SLC30A3 responds to glucose- and zinc variations in beta-cells and is critical for insulin production and in vivo glucose-metabolism during beta-cell stress. PLoS One 4: e5684.
73. Buffa L, Fuchs E, Pietropaolo M, Barr F, Solimena M, (2008) ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells. Eur J Cell Biol 87: 197-209.
74. Anderson AA, Helmering J, Juan T, Li CM, McCormick J, et al. (2009) Pancreatic islet expression profiling in diabetes-prone C57BLKS/J mice reveals transcriptional differences contributed by DBA loci, including Plagl1 and Nnt. Pathogenetics 2: 1.
75. Prada PO, Ropelle ER, Mourao RH, de Souza CT, Pauli JR, et al. (2009) EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice. Diabetes 58: 2910-2919.
76. Chong MP, Barritt GJ, Crouch MF, (2004) Insulin potentiates EGFR activation and signaling in fibroblasts. Biochem Biophys Res Commun 322: 535-541.
77. Shiraishi Y, Mizutani A, Yuasa S, Mikoshiba K, Furuichi T, (2004) Differential expression of Homer family proteins in the developing mouse brain. J Comp Neurol 473: 582-599.
78. Rong R, Ahn JY, Huang H, Nagata E, Kalman D, et al. (2003) PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis. Nat Neurosci 6: 1153-1161.
79. Arden KC, Viars CS, Fu K, Rozen R, (1995) Localization of short/branched chain acyl-CoA dehydrogenase (ACADSB) to human chromosome 10. Genomics 25: 743-745.
80. Ceddia RB, (2005) Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis. Int J Obes (Lond) 29: 1175-1183.
81. Kahn BB, Alquier T, Carling D, Hardie DG, (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15-25.
82. Dyck DJ, Steinberg G, Bonen A, (2001) Insulin increases FA uptake and esterification but reduces lipid utilization in isolated contracting muscle. Am J Physiol Endocrinol Metab 281: E600-607.
83. Topping DL, Mayes PA, (1972) The immediate effects of insulin and fructose on the metabolism of the perfused liver. Changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism. Biochem J 126: 295-311.
84. Storz P, Doppler H, Wernig A, Pfizenmaier K, Muller G, (1999) Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake. Eur J Biochem 266: 17-25.